comparemela.com
  1. Home
  2. Live Updates
  3. Prnewswire Zielbio Inc - Breaking News

Latest Breaking News On - Prnewswire zielbio inc - Page 2 : comparemela.com

ZielBio Announces First Patient Dosed in Phase 1/2 Clinical Trial of ZB131, Its Novel Monoclonal Antibody Targeting Cancer Specific Plectin

/PRNewswire/ ZielBio, Inc., a clinical stage biotechnology company discovering new treatments for cancer through its innovative ZielFind drug discovery.

Brian schwartzKimberly kellyPrnewswire zielbio inc

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.